Correlation Between Cardiol Therapeutics and China SXT

Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and China SXT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and China SXT into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiol Therapeutics Class and China SXT Pharmaceuticals, you can compare the effects of market volatilities on Cardiol Therapeutics and China SXT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of China SXT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and China SXT.

Diversification Opportunities for Cardiol Therapeutics and China SXT

-0.62

Correlation Coefficient

Cardiol Therapeutics  China SXT

Excellent diversification

The 3 months correlation between Cardiol and China is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and China SXT Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China SXT Pharmaceuticals and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with China SXT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China SXT Pharmaceuticals has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and China SXT go up and down completely randomly.

Pair Corralation between Cardiol Therapeutics and China SXT

Given the investment horizon of 90 days Cardiol Therapeutics Class is expected to generate 0.73 times more return on investment than China SXT. However, Cardiol Therapeutics Class is 1.37 times less risky than China SXT. It trades about 0.09 of its potential returns per unit of risk. China SXT Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  185.00  in Cardiol Therapeutics Class on February 28, 2024 and sell it today you would earn a total of  50.00  from holding Cardiol Therapeutics Class or generate 27.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Cardiol Therapeutics Class  vs.  China SXT Pharmaceuticals

Cardiol Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiol Therapeutics Class are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Cardiol Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

China SXT Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Cardiol Therapeutics and China SXT

The main advantage of trading using opposite Cardiol Therapeutics and China SXT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, China SXT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China SXT will offset losses from the drop in China SXT's long position.

The idea behind Cardiol Therapeutics Class and China SXT Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.